| Literature DB >> 36234530 |
Suke Lan1, Jiahao Zhang1, Xin Li1, Lejie Pan1, Juncheng Li1, Xian Wu2, Sheng-Tao Yang1.
Abstract
With the rapid development of metal-organic frameworks (MOF), the toxicity and environmental safety of MOF materials should be thoroughly investigated. The behaviors and bio-effects of MOF materials after oral exposure are largely unknown. In this study, we performed a pilot toxicity evaluation of MOF-74(Co) nanoparticles (NPs) both in vitro and in vivo. The cell viability and cell cycle were monitored after LO2 cells were incubated with MOF-74(Co). The Co contents, bodyweight, serum biochemistry, histopathological changes, and oxidative stress parameters were measured after oral exposure to MOF-74(Co) NPs in mice. LO2 cells showed viability loss at 100 mg/L. The cell cycle arrest was more sensitive, which was observed even at 12.5 mg/L. MOF-74(Co) NPs led to a significant accumulation of Co in the liver and kidneys. No bodyweight loss was observed and the serum biochemical index was mainly unchanged. Except for slight inflammation, the histopathological images of the liver and kidneys after oral exposure to MOF-74(Co) NPs were normal compared to the control. Meaningful oxidative stress was found in the liver and kidneys. The results collectively indicated the low toxicity of MOF-74(Co) NPs after oral exposure in mice.Entities:
Keywords: biodistribution; cell cycle arrest; metal-organic framework; nanoparticle; oral toxicity
Year: 2022 PMID: 36234530 PMCID: PMC9565312 DOI: 10.3390/nano12193398
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.719
Figure 1SEM image (a) and XRD spectrum (b) of MOF-74(Co) NPs. The arrows indicate the characteristic XRD peaks of MOF-74(Co) NPs.
Cytotoxicity of different MOF materials.
| MOF Material | Cell Line | Dose Range | IC50 | Ref. |
|---|---|---|---|---|
| MIL-160 | BEAS-2B | 1–750 mg/L | 421 mg/L | [ |
| Fe-MIL-101 | SKOV3 | 1.56–50 mg/L | 23.6 mg/L | [ |
| MOF-Zn2(1,4-bdc)2(dabco) | HuH7 | 0.01–10,000 mg/L | 1000 mg/L | [ |
| UiO-66 | HeLa | 10–100 mg/L | >100 mg/L | [ |
| IRMOF-3 | PC12 | 25–400 mg/L | 100 mg/L | [ |
| rMOF-FA | HeLa | 0–120 mg/L | 43 mg/L | [ |
| Cu-BTC | MCF7 | 0–75 mg/L | 3.49 mg/L | [ |
| HT-29 | >25 mg/L | |||
| HL-60 | >25 mg/L | |||
| NCI-H292 | >25 mg/L | |||
| Cu-MOF | MCF-7 | 0–200 mg/L | 109 mg/L | [ |
| MOF-74(Co) | LO2 cells | 0–100 mg/L | >100 mg/L | This study |
Figure 2Influence of MOF-74(Co) NPs on the cell viability (n = 4) (a) and cell cycle (b) of LO2 cells. * p < 0.05 compared to the control group.
Figure 3Co contents in organs after oral exposure to MOF-74(Co) NPs in mice at 1, 7, and 28 d (n = 3). * p < 0.05 compared to the control group.
Figure 4Serum biochemistry of mice after exposure to MOF-74(Co) (n = 4). * p < 0.05 compared to the control group.
Figure 5Histopathological observations of the liver after exposure to MOF-74(Co). The scale bar represents 50 μm.
Figure 6Histopathological observations of kidneys after exposure to MOF-74(Co). The scale bar represents 50 μm.
Figure 7Oxidative stress of liver and kidneys after exposure to MOF-74(Co) (n = 4). * p < 0.05 compared to the control group.